Preprint · OA
via OpenAlex
Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy
Chia‐Chen Liu, Takahisa Kanekiyo, Huaxi Xu, Guojun Bu
Nature Reviews Neurology · 2013 · ▲ 3,454 citations
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1038/nrneurol.2012.263
- Canonical
- link ↗
- Fetched
- 2026-10-29 MST
Cite this
APA
Liu, C., Kanekiyo, T., Xu, H., & Bu, G. (2013). Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. <em>Nature Reviews Neurology</em>. https://doi.org/10.1038/nrneurol.2012.263
Vancouver
Liu C, Kanekiyo T, Xu H, Bu G. Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nature Reviews Neurology. 2013. doi:10.1038/nrneurol.2012.263.
BibTeX
@unpublished{chiachen2013Apolip,
title = {Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy},
author = {Chia‐Chen Liu and Takahisa Kanekiyo and Huaxi Xu and Guojun Bu},
journal = {Nature Reviews Neurology},
year = {2013},
doi = {10.1038/nrneurol.2012.263},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Neuron 2013
Open access · OA
Biomarker Modeling of Alzheimer’s Disease
The Lancet 2021
Preprint · OA
Alzheimer's disease
Handbook of clinical neurology 2019
Citation only
Alzheimer's disease
Nature Reviews Neurology 2024
Preprint · OA
Is Alzheimer disease a disease?
Journal of Neural Transmission 2000
Citation only
Cell death mechanisms in Parkinson's disease
The Lancet Neurology 2016
Citation only